Brief: Rani Therapeutics Announces Initiation Of Phase 1 Study Of Rt-102 Oral Pth
23/03/2022 12:14
March 23 (Reuters) - Rani Therapeutics Holdings Inc
RANI.O :
* RANI THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1 STUDY OF
RT-102 ORAL PTH FOR OSTEOPOROSIS
Source text for Eikon: ID:nGNX3zgXjj
Further company coverage: RANI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition